Instructions to AuthorsScope
Author self-archiving/public access policy
SCOPE OF JOURNAL
Acta Biochimica et Biophysica Sinica is a scientific journal publishing monthly research papers, rapid communications and reviews in biochemistry, molecular biology and biophysics. Research papers and rapid communications should report original work not published or considered for publication elsewhere. Reviews should provide a concise introduction to the subject matter to inform the readers of the latest developments in a certain area.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for a manuscript are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by at least two anonymous reviewers and the editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
SUBMISSION OF MANUSCRIPTS
Manuscripts should be written in English and must be submitted online through our ScholarOne Manuscripts System. For full ScholarOne Manuscripts Instructions click here. Once you have prepared your manuscript according to the instructions please visit the online submission website.
Initial submission should include a cover letter (filling in the cover letter section) stating that: (i) the content has not been published or submitted for publication elsewhere and (ii) all authors are in the agreement with the content of the manuscript, attached with (i) the precise contribution of all authors to this manuscript respectively and (ii) the brief CV of the corresponding author. Authors must declare any financial support or relationships that may pose conflict of interest. If tables or figures have been reproduced from other sources, a letter from the copyright holder (usually the Publisher) stating authorization to reproduce the material must be attached to the covering letter.
Submission of revised manuscript should include: (i) the revised manuscript with revisions marked, (ii) a letter answering all reviewers’ questions point by point.
Submission of the final manuscript should include: (i) the revised manuscript with revisions marked. (ii) an agreement on transferring the copyright to the Institute of Biochemistry and
If you have difficulties in using the online submission system, please feel free to contact the Editorial Office at the following address:
Editorial Office of Acta Biochimica et Biophysica Sinica
The Institute of Biochemistry and Cell Biology, SIBS, CAS
320 Yueyang Road, Shanghai 200031, China
Copyright of any article published in ABBS will belong to the author or their designee. However, it is a condition of publication in the journal that authors grant an exclusive licence to publish to Oxford University Press. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and allows the article to be as widely disseminated as possible. As part of the licence agreement, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and Oxford University Press as the Publisher. Manuscripts will not be published without submission of an original signed copyright form.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder. Signed patient consent forms must be obtained for recognizable photographs. Submission of the manuscript will be taken to indicate the authors compliance with these conditions.
Upon receipt of accepted manuscripts at Oxford Journals authors will be invited to complete an online copyright licence to publish form.
Please note that by submitting an article for publication you confirm that you are the corresponding/submitting author and that Oxford University Press ("OUP") may retain your email address for the purpose of communicating with you about the article. You agree to notify OUP immediately if your details change. If your article is accepted for publication OUP will contact you using the email address you have used in the registration process. Please note that OUP does not retain copies of rejected articles.
The corresponding author will be asked to complete the online licence to publish form upon acceptance of their manuscript. No article will be published unless the licence has been received at Oxford Journals.
As the Author(s), copyright of the Article remains yours (or your employer’s if your employer claims copyright in your work). See here for full details of Oxford Journals' copyright policy.
ABBS authors have the option to publish their paper under the Oxford Open initiative; whereby, for a charge, their paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to accept a mandatory licence to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged.
Oxford Open articles are published under Creative Commons licences. Authors publishing in ABBS can use the following creative commons licences for their articles:
• Creative Commons Attribution licence (CC BY)
• Creative Commons Non-Commercial licence (CC BY-NC)
• Creative Commons non-Commercial No Derivatives licence (CC BY-NC-ND)
Please click here for more information about the Creative Commons licences.
You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The Open Access charges applicable are:
Regular charge - £1850/ $3000 / €2450
Reduced Rate Developing country charge* - £925 / $1500 / €1225
Free Developing country charge* - £0 /$0 / €0
*Visit our Developing Countries page for a list of qualifying countries
The manuscript handling fee and publication fee will be waived if the authors choose Open Access model and pay Open Access charges, please note that the colour charges are in addition to the Open Access charge.
Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.
Abbreviations should be used sparingly: only where they ease the reader's task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Genetic nomenclature Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: 'These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.' Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
FORMAT OF MANUSCRIPT
An example of the correct format for submitted papers is available on our website. Research papers should be arranged in the following order: (i) title, author(s) and affiliation(s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) materials and methods; (vi) results; (vii) discussion; (viii) references; (ix) footnote; (x) figure legends; (xi) tables; (xii) figures. Rapid communications should be arranged in the following order: (i) title, author(s) and affiliation (s); (ii) running title; (iii) abstract and keywords; (iv) introduction; (v) experimental procedures; (vi) results and discussion; (vii) references; (viii) footnote; (ix) figure legends; (x) tables; (xi) figures. The locations of figures and tables in the text should be indicated. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title: The title should be short and informative, less than 20 words, and should not include non-standard acronyms or abbreviations.
Title page: The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Running title: A running title should be provided and should be less than 60 characters.
Abstract: The abstract should describe clearly the aim, major findings and conclusions of the research. It must not exceed 250 words.
Keywords: Five or fewer key words should be listed below the abstract. Keywords should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html
Introduction: The basic principles of research, background, earlier related work and the purpose of the present studies should be described in the introduction.
Experimental procedures: Experimental procedures should be brief but complete enough to be repeated; procedures published previously should be cited in references.
Results: It is recommended that results be presented in figures and tables along with a suitable description in the text.
Discussion: The discussion should be concise (no more than three pages) and focus on the interpretation of the results.
References: The Vancouver system of referencing should be used (examples are given below). In the text, references should be marked using [Arabic numerals] in the order in which they appear.
In the reference list, if a reference has many authors, list only the first seven authors, followed by 'et al.' Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated according to the style used in Index Medicus. Authors are responsible for the accuracy of the references.
1 Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001, 276: 27584-7590.
2 Hanahan D, Jessee J, Bloom FR. Techniques for transformation of E. coli. In: Glover DM, Hames BD eds. DNA Cloning: A Practical Approach. 2nd ed. England: Oxford University Press 1998, 122-123.
Footnotes: A footnote below the key words can include (1) source of grants, (2) present address of any author(s) if required, and (3) abbreviations used in the text.
Tables: Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be consecutively numbered in the text in Arabic numerals. Legends should be concise but comprehensive: the table, legend and footnotes must be understandable without reference to the text. Vertical grid lines should not be used to separate columns. Each column in a table must have a heading, with units of measurement in parentheses; all abbreviations must be defined in footnotes.
Language Editing: Particularly if English is not your first language, before submitting your manuscript you may wish to have it edited for language. This is not a mandatory step, but may help to ensure that the academic content of your paper is fully understood by journal editors and reviewers. Language editing does not guarantee that your manuscript will be accepted for publication. If you would like information about such services please click here. There are other specialist language editing companies that offer similar services and you can also use any of these. Authors are liable for all costs associated with such services.
Please be aware that the requirements for online submission and for reproduction in the journal are different: (i) for online submission and peer review, please upload your figures either embedded in the word processing file or separately as low-resolution images (.jpg, .tif, .gif or. eps); (ii) for reproduction in the journal, you will be required after acceptance to supply high-resolution .tif files (1200 d.p.i. for line drawings and 300 d.p.i. for colour and half-tone artwork) or high-quality printouts on glossy paper. We advise that you create your high-resolution images first as these can be easily converted into low-resolution images for online submission.
For useful information on preparing your figures for publication, go to http://cpc.cadmus.com/da/index.jsp. Figures will not be relettered by the publisher. The journal reserves the right to reduce the size of illustrative material. Any photomicrographs, electron micrographs or radiographs must be of high quality. Wherever possible, photographs should fit within the print area of 169 x 235 mm (full page) or within the column width of 82 mm. Photomicrographs should provide details of staining technique and a scale bar. Patients shown in photographs should have their identity concealed or should have given their written consent to publication. Normally no more than six illustrations will be accepted for publication in the print issue without charge.
Figures should be cited in consecutive order in the text, if possible. Graphs should be drawn professionally or with a computer graphics package. Pictures should be supplied electronically. Individual photographs forming a composite figure should be of equal contrast. Magnifications should be indicated using a scale bar on the illustration.
Figure legends should be concise but comprehensive: the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
The quality of reproduction is limited by the quality of the submitted material. All figures must be of high quality - they should be sharply focused, have good contrast and any lettering must be clear and legible. Colour illustrations can be reproduced if there is sufficient scientific merit in doing so. Authors will be expected to bear the cost of colour origination by the Journal’s printers.
Guidance for preparation of Figures
Figures should be sized to fit a single column of the Journal where possible (88 mm) or a double column if necessary (180 mm). The preferred font for lettering is Times; lettering should have an upper case height of 2 mm and a lower case height of 1 mm at publication size (corresponding to point size 8). Line thickness should be set at 0.5 points. Shading used on line drawings should be clear and distinctive; shades of grey and heavy stippling do not reproduce well. Lines and symbols should be drawn boldly enough to withstand reduction. The preferred symbols are filled circles, open circles, filled squares, open squares, filled triangles and open triangles, and should be no smaller than 1 mm (height/diameter) at publication size. Part labels should be lower case letters within parentheses, e.g. (a), (b), (c) etc.
The following rules should be followed:
The sentence should begin: ‘This work was supported by …’
The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI' (one of the 27 subinstitutions) or 'NCI at NIH’ - see the full RIN-approved list of UK funding agencies for details
Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’
Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)
Where individuals need to be specified for certain sources of funding the following text should be added after the relevant agency or grant number 'to [author initials]'.
An example is given here: ‘This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.]
and the Alcohol & Education Research Council [HFY GR667789].
Oxford Journals will deposit all NIH-funded articles in PubMed Central. See Depositing articles in repositories – information for authors for details. Authors must ensure that manuscripts are clearly indicated as NIH-funded using the guidelines above.
Crossref Funding Data Registry
In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about the CHORUS initiative please click here.
CONFLICT OF INTEREST
Conflicts of interest have the potential to affect authors, referees and Editors. ABBS has the following systems in place to deal with conflicts of interest:
Authors. Authors are required to include a Transparency declarations section in every submission to the Journal (for details see below).
Referees. When invited to act, and again when they agree to act, referees are reminded to consider whether they have any potential conflicts of interest. Referees are asked to discuss any perceived potential conflict with the Editor of the article who will reach a decision as to whether it is appropriate that the referee acts on the article or whether they should withdraw.
Editors. The Editor-in-Chief and Editors register their interests (including personal and business interests) with the Society. When an article is assigned to an Editor the Editor is reminded to consider whether there are any potential conflicts of interest, and if so, to discuss them with the Editor-in-Chief, who will come to a decision as to whether it is appropriate for the Editor to act on the article, or whether it should be reassigned.
obtain permission from the original publisher and, if requested, the original author (i.e. the corresponding author of the article from which the figure/table has come) for reproducing/modifying figures/tables.
request the following when seeking to reproduce any kind of third party material:
(i) non-exclusive rights to reproduce the material in the specified article and journal.
(ii) print and electronic rights, preferably for use in any form or medium.
(iii) the right to use the material for the life of the work.
(iv) world-wide English-language rights. If rights for all languages can be secured, this is preferable.
(v) the right to use images with a resolution of 150 dpi in the PDF version of the journal or 72 dpi in the HTML version.
include a statement indicating that permission has been obtained in the relevant legend/footnote.
provide the Editorial Office with copies of any relevant paperwork.
For further details, as well as a template permissions request letter, please contact the Editorial Office.
Third-Party Content in Open Access papers
If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:
Title of content
Author, Original publication, year of original publication, by permission of [rights holder]
This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.
Only directly relevant experimental data should be included in the full text of manuscripts. Supporting data should be submitted for review as supplementary material, in a separate file from the manuscript, for publication online only. Material that has not been peer-reviewed will be made available only through a link to the author's home page, at the discretion of the Editor. Supplementary Material can be published in these formats: .txt, .htslp, .shtml, .html, .htm, .jpg, .jpeg, .gif, .mov, .mpg, .avi, .pdf, .xls, .zip, .doc, .rtf, .tif, .dtl.
Authors will receive a PDF file of the complete paper by email. In the interest of speed, corrections must be returned within 48 hours.
A manuscript handling fee of US$ 30 (200RMB) is required for a manuscript selected to be peer-reviewed. A publication fee of US$ 60 (400RMB) per printed page is required (this fee will be waived if authors choose Open Access model and pay Open Access charges). No additional charge is required for black-white figures. A surcharge of US$ 200 (1200 RMB) is required for each colour page reproduced in the journal.
Authors unable to pay publication fee may apply at the time of submission for a waiver. Application forms must be signed by the senior official of the institution with which the corresponding author is affiliated and sent to the editorial office mail or by Fax (+86-21-5492-0954).
Fees should be paid to Acta Biochimica et Biophysica Sinica by Telegraph Transfer or Money Order. Please provide your manuscript ID number in the remark.
(1) Telegraph transfer
ITEM TITLE: Publication fee paid to Acta Biochimica et Biophysica Sinica
RECEIVING BANK: Agricultural Bank of China, Shanghai Branch, Xuhui Sub-Branch
SWIFT CODE: ABOCCNBJ090.
A/C Title: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
A/C No: 033924-00801048006
ADDRESS: 320 Yueyang Road, Shanghai 200031, China
(2) Money Order
PAYABLE TO: Acta Biochimica et Biophysica Sinica
MAILING ADDRESS: Room 407, Building 31B, 319 Yueyang Road, Shanghai 200031, China
The Journal will provide the authors with free online access to their article, with the option of purchasing printed offprints. Offprints can be ordered using the Oxford Journals Author Services site. Late orders submitted after the Journal has been printed are subject to increased prices.
AUTHOR SELF-ARCHIVING/PUBLIC ACCESS POLICY
For information about this journals policy, please visit our Author Self-Archiving policy page.